Generation Bio has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with six publications in Q2 2024

The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 50% of filings. The World Intellectual Property Organization(WIPO), European Patent Office(EPO), Israel(IL), and South Korea(KR) patent Office are among the top ten patent offices where Generation Bio is filings its patents..

University of Pennsylvania could be the strongest competitor for Generation Bio

Patents related to nanomedicine and rare diseases lead Generation Bio's portfolio

Generation Bio has the highest number of patents in nanomedicine followed by, rare diseases and cell & gene therapy. For nanomedicine, nearly 77% of patents were filed and no patents were granted in Q2 2024.

Progressive familial intrahepatic cholestasis related patents lead Generation Bio portfolio followed by hypoxia

Generation Bio has highest number of patents in progressive familial intrahepatic cholestasis followed by hypoxia.

For comprehensive analysis of Generation Bio's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.